Maryland 2025 2025 Regular Session

Maryland Senate Bill SB224 Introduced / Bill

Filed 01/03/2025

                     
 
EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW. 
        [Brackets] indicate matter deleted from existing law. 
          *sb0224*  
  
SENATE BILL 224 
J1   	5lr0265 
  	(PRE–FILED) 	CF HB 94 
By: Chair, Finance Committee (By Request – Departmental – Health) 
Requested: October 6, 2024 
Introduced and read first time: January 8, 2025 
Assigned to: Finance 
 
A BILL ENTITLED 
 
AN ACT concerning 1 
 
Opioid–Associated Disease Prevention and Outreach Programs – Appeals and 2 
Membership of Standing Advisory Committee 3 
 
FOR the purpose of authorizing a local health department or community –based 4 
organization to appeal to the Secretary of Health or the Secretary’s designee, rather 5 
than to the Deputy Secretary for Public Health Services, an adverse decision of the 6 
Maryland Department of Health and a local health officer regarding an application 7 
for authorization to operate an Opioid–Associated Disease Prevention and Outreach 8 
Program; altering the membership of the Standing Advisory Committee on 9 
Opioid–Associated Disease Prevention and Outreach Programs; and generally 10 
relating to Opioid–Associated Disease Prevention and Outreach Programs. 11 
 
BY repealing and reenacting, without amendments, 12 
 Article – Health – General 13 
Section 24–901(a) and (f) 14 
 Annotated Code of Maryland 15 
 (2023 Replacement Volume and 2024 Supplement) 16 
 
BY repealing and reenacting, with amendments, 17 
Article – Health – General 18 
Section 24–902, 24–904, and 24–905 19 
Annotated Code of Maryland 20 
(2023 Replacement Volume and 2024 Supplement) 21 
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY O F MARYLAND, 22 
That the Laws of Maryland read as follows: 23 
 
Article – Health – General 24 
 
24–901. 25  2 	SENATE BILL 224  
 
 
 
 (a) In this subtitle the following words have the meanings indicated. 1 
 
 (f) “Program” means an Opioid–Associated Disease Prevention and Outreach 2 
Program. 3 
 
24–902. 4 
 
 (a) (1) A Program may be established by a local health department or a 5 
community–based organization, subject to the provisions of this subtitle. 6 
 
 (2) (i) A county may cooperate with another county to establish a 7 
Program. 8 
 
 (ii) A community–based organization may establish a multicounty 9 
Program. 10 
 
 (3) This subtitle does not apply to the AIDS Prevention Sterile Needle and 11 
Syringe Exchange Pilot Program established under Subtitle 8 of this title. 12 
 
 (b) (1) (i) A local health department or community–based organization 13 
shall apply to the Department and a local health officer for authorization to operate a 14 
Program. 15 
 
 (ii) A local health department or community–based organization 16 
may apply at any time for authorization to operate a Program under subparagraph (i) of 17 
this paragraph. 18 
 
 (2) The Department and a local health officer jointly shall issue an 19 
authorization determination based on the ability of a Program to meet the requirements of 20 
this subtitle. 21 
 
 (3) The Department and a local health officer shall: 22 
 
 (i) Approve or deny an application for authorization to operate a 23 
Program within 60 days after receiving a complete application; and 24 
 
 (ii) Provide to the applicant a written explanation of the decision of 25 
the Department and local health officer. 26 
 
 (4) (i) A local health department or community–based organization 27 
may appeal an adverse decision by the Department and a local health officer to the 28 
[Deputy] Secretary [for Public Health Services] OR THE SECRETARY’S DESIGNEE. 29 
 
 (ii) The [Deputy] Secretary OR THE SECRETARY’S DESIGNEE 30 
shall: 31 
   	SENATE BILL 224 	3 
 
 
 1. Grant or deny an appeal within 60 days after receiving an 1 
appeal; and 2 
 
 2. Provide a written explanation of the [Deputy] Secretary’s 3 
OR THE SECRETARY’S DESIGNEE’S decision to the local health department or 4 
community–based organization. 5 
 
 (c) If established under subsection (a) of this section, a Program shall: 6 
 
 (1) Provide for substance use outreach, education, and linkage to treatment 7 
services to participants, including distribution and collection of hypodermic needles and 8 
syringes; and 9 
 
 (2) Operate in accordance with: 10 
 
 (i) The technical assistance of the Standing Advisory Committee; 11 
and 12 
 
 (ii) The procedures, plans, and protocols approved by: 13 
 
 1. The local health officer for each county in which a Program 14 
is established; and 15 
 
 2. The Department. 16 
 
24–904. 17 
 
 (a) The Department shall appoint a Standing Advisory Committee on 18 
Opioid–Associated Disease Prevention and Outreach Programs. 19 
 
 (b) The Standing Advisory Committee shall consist of: 20 
 
 (1) The [Deputy] Secretary [for Public Health Services] OR THE 21 
SECRETARY’S DESIGNEE; 22 
 
 (2) One individual from academia who specializes in public health issues 23 
related to substance–related disorders or infectious diseases; 24 
 
 (3) One representative from law enforcement, nominated by the Executive 25 
Director of the Governor’s Office of Crime Prevention and Policy; 26 
 
 (4) One individual with expertise in the prevention of HIV or viral 27 
hepatitis; 28 
 
 (5) One health care practitioner with experience providing services to 29 
individuals who inject drugs; 30 
  4 	SENATE BILL 224  
 
 
 (6) One individual with substance use experience; 1 
 
 (7) One family member of an individual who injects or has injected drugs; 2 
 
 (8) One representative of local law enforcement; 3 
 
 (9) One local health officer; 4 
 
 (10) One representative of a local or regional hospital; 5 
 
 (11) One individual with experience in syringe services programs; and 6 
 
 (12) Any additional members recommended by the Department. 7 
 
 (c) The [Deputy] Secretary [for Public Health Services] OR THE SECRETARY’S 8 
DESIGNEE shall serve as chair of the Standing Advisory Committee. 9 
 
 (d) The Standing Advisory Committee shall: 10 
 
 (1) Provide technical assistance to each Program on developing: 11 
 
 (i) Program operating procedures for collection and distribution of 12 
hypodermic needles and syringes; 13 
 
 (ii) A plan for community outreach and education; and 14 
 
 (iii) A protocol for linking Program participants to substance–related 15 
disorder treatment and recovery services; and 16 
 
 (2) Make recommendations to a Program regarding any aspect of Program 17 
procedures or operation. 18 
 
24–905. 19 
 
 (a) The Department shall: 20 
 
 (1) Adopt regulations for the implementation of this subtitle, in 21 
consultation with the Standing Advisory Committee and the Maryland Association of 22 
County Health Officers; and 23 
 
 (2) Ensure the provision of technical assistance to a Program about best 24 
practices, best practice protocols, and other subject areas. 25 
 
 (b) The regulations adopted under subsection (a)(1) of this section shall establish: 26 
 
 (1) Procedures for ensuring the security of Program locations and 27 
equipment; 28   	SENATE BILL 224 	5 
 
 
 
 (2) An appeals process for appeals authorized by § 24–902(b)(4) of this 1 
subtitle, including the standard of review that the [Deputy] Secretary [for Public Health 2 
Services] OR THE SECRETARY’S DESIGNEE must apply when reviewing a decision of the 3 
Department and a local health officer; and 4 
 
 (3) Procedures for data collection and Program evaluation. 5 
 
 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect July 6 
1, 2025. 7